Janus Henderson Group
RXST icon

Janus Henderson Group’s RxSight RXST Stock Holding History

Janus Henderson Group’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14,500
Closed -$188K – 2460
2025
Q2 		$188K Hold
14,500
– – ﹤0.01% 2332
2025
Q1 		$385K Hold
14,500
– – ﹤0.01% 2093
2024
Q4 		$498K Hold
14,500
– – ﹤0.01% 2036
2024
Q3 		$716K Buy
14,500
+3,800
+36% +$195K ﹤0.01% 1847
2024
Q2 		$643K Sell
10,700
-154
-1% -$8.8K ﹤0.01% 1860
2024
Q1 		$559K Buy
10,854
+10
+0.1% +$491 ﹤0.01% 1954
2023
Q4 		$437K Sell
10,844
-10
-0.1% -$293 ﹤0.01% 2057
2023
Q3 		$303K Buy
10,854
+20
+0.2% +$596 ﹤0.01% 2182
2023
Q2 		$312K Buy
+10,834
New +$241K ﹤0.01% 2229

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Janus Henderson Group's RXST Position: Q3 2025 in Review

Janus Henderson Group sold out of RxSight (RXST) in Q3 2025, closing a stake of 14,500 shares — an estimated $188K sold.

Janus Henderson Group first reported a position in RXST in Q2 2023 and held it in 9 quarters. The position peaked at $716K in Q3 2024. 160 funds tracked by Wall St. Rank hold RXST as of Q3 2025.

  • Janus Henderson Group reported no remaining RxSight position as of Q3 2025 after selling out during the quarter.
  • Janus Henderson Group sold 14,500 RxSight shares in Q3 2025, an estimated $188K.
  • Janus Henderson Group first reported a position in RxSight in Q2 2023 and held it in 9 quarters.
  • Janus Henderson Group's RxSight position peaked at $716K in Q3 2024.
  • 160 funds tracked by Wall St. Rank held RxSight as of Q3 2025.

Based on Janus Henderson Group's 13F filing for Q3 2025, filed 14 Nov 2025.